The CK5 and CK6 expression status was unrelated to overall patient survival in breast cancer (Supplementary Fig. 2a–c) and recurrence-free survival in patients treated by cystectomy for their urothelial carcinomas (Supplementary Fig. 2e–g). This evidence concerns the gene KRT5 and breast cancer.